PHARMAHOLD LB
ActiveSummary
For PHARMAHOLD LB, one filing cycle of the annual accounts is missing. The 2024 annual accounts show equity of €974,659 and a net result of -€1,829. Equity remains stable across the filed financial years (±0.1% per year). Its solvency ranks better than 95% of 15,190 sector peers (NACE 69, financial year 2024). The company has been active since 1995 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.7% (low).
Group and network
Part of the group
TERRA FECUNDA
37 companies
Group, risk and exposure
Shared directorsBundled connections
Connections & network
23 connected companiesThis company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
ARDEA
Shared corporate director
→
ARDEA ALBA
Shared corporate director
→
ARDEA INTERMEDIA
Shared corporate director
→
ARLACO
Shared corporate director
→
Show 19 more companies with a shared director
CITESILE
Shared corporate director
→
COOMANS IMMO
Shared corporate director
→
DECOSIM
Shared corporate director
→
DULLE GRIET
Shared corporate director
→
ETABLISSEMENTS FE BRASSEUR
Shared corporate director
→
EXPRESCO
Shared corporate director
→
FAP AGRO
Shared corporate director
→
FAP RETAIL
Shared corporate director
→
FAP WIELSBEKE
Shared corporate director
→
IMMOJECO
Shared corporate director
→
KOLMONT
Shared corporate director
→
Marnepol
Shared corporate director
→
Phenix Development
Shared corporate director
→
Roggim
Shared corporate director
→
Romingo
Shared corporate director
→
ROMINGO II
Shared corporate director
→
Vestico
Shared corporate director
→
WEGA
Shared corporate director
→
Ymiluco
Shared corporate director
→